GenMark Diagnostics said this week that it has submitted a respiratory viral panel for use on its eSensor XT-8 system to the US Food and Drug Administration for 510(k) clearance.
The test is designed to identify multiple viruses from individuals showing symptoms of respiratory infection.
Nanosphere said this week that it has obtained a CE IVD Mark for a gram-positive blood culture nucleic acid test that runs on its automated Verigene system.
The BC-GP test provides genus- and species-level detection for a broad panel of clinically significant gram-positive bacteria, as well as markers for antibiotic resistance, including the mecA, vanA, and vanB genes.
The test provides results within two and a half hours, which the company said improves upon current microbiological methods that can take two to three days.